Floatz logo

124 assets in Leukemia

Therapeutic assets addressing Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cytokine Induced Memory-Like Natural Killer Cells
Leukemia
Dana-Farber Cancer InstituteP1C (37)
Cytokine-Induced Memory-Like Natural Killer Cells
Leukemia
Dana-Farber Cancer InstituteP1C (37)
Dalbavancin
Leukemia
St. Jude Children's Research HospitalP1C (37)
Eganelisib
Leukemia
Jacqueline Garcia, MDP1C (37)
Gilteritinib
Leukemia
Kura Oncology, Inc.P1C (37)
Kappa Cd28 T Cells
Leukemia
Baylor College of MedicineP1C (37)
Karonudib
Leukemia
Thomas Helleday FoundationP1C (37)
Levofloxacin Iv
Leukemia
St. Jude Children's Research HospitalP1C (37)
Scri-Hucar19V2
Leukemia
Seattle Children's HospitalP1C (37)
Talazoparib
Leukemia
Dana-Farber Cancer InstituteP1C (37)
Vyxeos
Leukemia
Children's Hospital Medical Center, CincinnatiP1C (37)
Ziftomenib
Leukemia
Kura Oncology, Inc.P1C (37)
Bisoprolol Fumarate
Leukemia
University of ArizonaEarly P1C (34)
Bite-Ev
Leukemia
Beijing GoBroad HospitalEarly P1C (34)
Carvedilol
Leukemia
University of ArizonaEarly P1C (34)
Isoproterenol
Leukemia
University of ArizonaEarly P1C (34)
Nadolol
Leukemia
University of ArizonaEarly P1C (34)
Roflumilast
Leukemia
University of ArizonaEarly P1C (34)
Gamma-Delta (??) T Cells
Leukemia
Guangzhou Bio-gene Technology Co., LtdEarly P1C (33)
6-(4-(1,1-Dimethylethyl)phenoxy)-3-pyridinamine
Leukemia
M.D. Anderson Cancer CenterP2D (29)
Rivogenlecleucel
Leukemia
Bellicum PharmaceuticalsP1D (29)
Apixaban
Leukemia
Medical University of GdanskN/AD (28)
Enoxaparin
Leukemia
Medical University of GdanskN/AD (28)
Rivaroxaban
Leukemia
Medical University of GdanskN/AD (28)
Showing 101 to 124 of 124 assets
PreviousPage 3 of 3Next